US 9023356
Treatment method using EGFR antibodies and SRC inhibitors and related formulations
granted A61KA61K31/506A61K31/517
Quick answer
US patent 9023356 (Treatment method using EGFR antibodies and SRC inhibitors and related formulations) held by The Regents of the University of California expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/506, A61K31/517, A61K39/39541, A61K45/06